U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. Haemophilus B Conjugate Vaccine (Meningococcal Protein Conjugate)
  1. Vaccines

Haemophilus B Conjugate Vaccine (Meningococcal Protein Conjugate)

STN #: BL 103237/5285
Proper Name: Haemophilus B Conjugate Vaccine (Meningococcal Protein Conjugate) 
Tradename: Liquid PedvaxHIB
Manufacturer: Merck Sharp & Dohme Corp.
Indication: Liquid PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age.

Product Information

Supporting Documents

Back to Top